Third FDA panel member quits over Alzheimer’s drug approval


Sumary of Third FDA panel member quits over Alzheimer’s drug approval:

  • Aaron Kesselheim, a Professor of Medicine at Harvard Medical School who had served on the FDA advisory committee for nervous system drugs since 2015, told Reuters on Thursday he was stepping down from the panel..
  • On Tuesday, a member of the advisory group who voted against the approval, Washington University neurologist Dr. Joel Perlmutter, resigned from the committee, citing the FDA approval of Aduhelm….

Want to know more click here go to source.

From -
Generic selectors
Exact matches only
Search in title
Search in content

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.